Bo Wei

8PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersProteomics and metabolomicsReaction engineering (excl. nuclear reactions)Molecular targetsInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 09, 2026
Inflammatory neuropathy in mouse and primate models of colorectal cancer.

|Feb 09, 2026
High-throughput multi-organ proteomics workflow for drug efficacy and toxicity analysis.

Yun Xiong, Lin Tan, Wai-Kin Chan

|Jan 30, 2026
Supercharging-enhanced nDIA-MS enables global profiling of drug-induced proteome solubility shifts.

Yun Xiong, Huimin Zhang, Lin Tan

|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

Feiyu Chen, Haoyan Li, Yin Wang

|Feb 05, 2025
Ion suppression correction and normalization for non-targeted metabolomics.

Iqbal Mahmud, Bo Wei, Lucas Veillon

|Oct 11, 2024
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.

Chandrani Chattopadhyay, Janos Roszik, Rajat Bhattacharya

Pageof 2

Frequent Collaborators

8 joint publications

Philip L Lorenzi

5 joint publications

Iqbal Mahmud

3 joint publications

John N Weinstein

2 joint publications

Rehan Akbani